RCAMU
MDT icon

Rothschild & Co Asset Management US’s Medtronic MDT Stock Holding History

Rothschild & Co Asset Management US’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-499,533
Closed -$55.4M – 271
2022
Q1 		$55.4M Sell
499,533
-7,340
-1% -$775K 0.71% 46
2021
Q4 		$52.4M Sell
506,873
-606,054
-54% -$70.2M 0.62% 47
2021
Q3 		$140M Sell
1,112,927
-16,976
-2% -$2.2M 1.73% 8
2021
Q2 		$140M Buy
1,129,903
+37,340
+3% +$4.69M 1.66% 6
2021
Q1 		$129M Buy
1,092,563
+26,292
+2% +$3.08M 1.59% 5
2020
Q4 		$125M Buy
1,066,271
+431,695
+68% +$47.5M 1.61% 4
2020
Q3 		$65.9M Sell
634,576
-184,705
-23% -$18.5M 1.19% 6
2020
Q2 		$75.1M Sell
819,281
-82,900
-9% -$7.95M 1.11% 8
2020
Q1 		$81.4M Sell
902,181
-41,701
-4% -$4.44M 1.27% 6
2019
Q4 		$107M Sell
943,882
-45,504
-5% -$4.99M 1.11% 6
2019
Q3 		$107M Sell
989,386
-31,193
-3% -$3.25M 1.16% 5
2019
Q2 		$99.4M Buy
1,020,579
+31,718
+3% +$2.9M 1.06% 9
2019
Q1 		$90.1M Buy
988,861
+144,301
+17% +$12.9M 0.97% 11
2018
Q4 		$76.8M Buy
844,560
+205,587
+32% +$19.2M 0.93% 11
2018
Q3 		$62.9M Buy
638,973
+5,504
+0.9% +$509K 0.64% 21
2018
Q2 		$54.2M Sell
633,469
-835
-0.1% -$69.7K 0.58% 38
2018
Q1 		$50.9M Sell
634,304
-34,594
-5% -$2.85M 0.57% 44
2017
Q4 		$54M Sell
668,898
-63,527
-9% -$5.09M 0.57% 43
2017
Q3 		$57M Sell
732,425
-23,708
-3% -$1.97M 0.63% 38
2017
Q2 		$67.1M Sell
756,133
-12,079
-2% -$1.02M 0.76% 22
2017
Q1 		$61.9M Buy
768,212
+33,574
+5% +$2.62M 0.71% 28
2016
Q4 		$52.3M Buy
734,638
+419,200
+133% +$32.9M 0.67% 29
2016
Q3 		$27.3M Sell
315,438
-18,929
-6% -$1.65M 0.47% 63
2016
Q2 		$29M Buy
334,367
+38,844
+13% +$3.14M 0.52% 41
2016
Q1 		$22.2M Buy
+295,523
New +$22.3M 0.42% 70

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rothschild & Co Asset Management US's MDT Position: Q2 2022 in Review

Rothschild & Co Asset Management US sold out of Medtronic (MDT) in Q2 2022, closing a stake of 499,533 shares — an estimated $55.4M sold.

Rothschild & Co Asset Management US first reported a position in MDT in Q1 2016 and held it in 25 quarters. The position peaked at $140M in Q2 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Rothschild & Co Asset Management US reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 499,533 Medtronic shares in Q2 2022, an estimated $55.4M.
  • Rothschild & Co Asset Management US first reported a position in Medtronic in Q1 2016 and held it in 25 quarters.
  • Rothschild & Co Asset Management US's Medtronic position peaked at $140M in Q2 2021.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2022, filed 9 Aug 2022.